A Nurse Practitioner led opiate substitution prescribing clinic The

Similar documents
Getting help for a drug problem A guide to treatment

Policy for the issue of permits to prescribe Schedule 8 poisons

Support to Primary Care from Derbyshire Substance Misuse Service for prescribed / OTC drug dependence

MEDICAL ASSISTANCE BULLETIN

The prevalence of use of psychotropic drugs, buprenorphine and methadone on the streets, the polyuse of substances in Finland

MEDICAL ASSISTANCE BULLETIN

Specialist Alcohol & Drug Services in Lanarkshire

Information for Pharmacists

APPLICATION FOR Page 1/7 RESIDENTIAL TREATMENT

An integrated approach to addressing opiate abuse in Maine. Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009

Frequently asked questions

Care Management Council submission date: August Contact Information

Rekindling House Dual Diagnosis Specialist

SUBOXONE /VIVITROL WEBINAR. Educational Training tool concerning the Non-Methadone Medication Assisted Treatment Policy that is Effective on 1/1/12

We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.

State Policies and Adoption of Buprenorphine: Summary Results of Telephone Interviews with State Agency Staff

Resources for the Prevention and Treatment of Substance Use Disorders

SCOTTISH PRISON SERVICE DRUG MISUSE AND DEPENDENCE OPERATIONAL GUIDANCE

Title: Opening Plenary Session Challenges and Opportunities to Impact the Opioid Dependence Crisis

MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION

Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling

Opiate Abuse and Mental Illness

Ever wish you could... Quit using heroin? Protect yourself from HIV infection? Get healthier?

TREATMENT MODALITIES. May, 2013

Prior Authorization Guideline

Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions

DRUG AND ALCOHOL DETOXIFICATION: A GUIDE TO OUR SERVICES

Guidelines for the Prescribing, Supply and Administration of Methadone and Buprenorphine on Transfer of Care

Federal Regulations For Prescribing Scheduled Controlled Substances

MAT Disclosures & Consents 1 of 6. Authorization & Disclosure

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians

Opiate Addiction, Pharmacological Treatment Approaches CO-OCCURRING MENTAL HEALTH DISORDERS JOSEPH A. BEBO MA, CAGS, LADC1

Use of Pharmacotherapies by Substance Abuse Treatment Facilities

2015 REPORT Steven W. Schierholt, Esq. Executive Director

Treatments for drug misuse

DMRI Drug Misuse Research Initiative

Patient Information and Consent to Treatment with Buprenorphine

SAMHSA Initiatives to Educate Prescribers and Consumers and Treatment Resources

Beyond SBIRT: Integrating Addiction Medicine into Primary Care

Treatment Approaches for Drug Addiction

Discontinuation: Involuntary Discharge

Opioid overdose can occur when a patient misunderstands the directions

Prescription Drug Addiction

Southlake Psychiatry. Suboxone Contract

How To Treat Anorexic Addiction With Medication Assisted Treatment

(Health Scrutiny Sub-Committee 9 March 2009)

The ACT Opioid Maintenance Treatment Guidelines

Patients are still addicted Buprenorphine is simply a substitute for heroin or

Sample Patient Agreement Forms

Minimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:

Treatment Approaches for Drug Addiction

RULES OF THE TENNESSEE DEPARTMENT OF MENTAL HEALTH AND DEVELOPMENTAL DISABILITIES

Implementing Prescribing Guidelines in the Emergency Department. April 16, 2013

Using Drugs to Treat Drug Addiction How it works and why it makes sense

SENATE BILL 871. By Dickerson BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF TENNESSEE:

SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK

THE BASICS. Community Based Medically Assisted Alcohol Withdrawal. World Health Organisation The Issues 5/18/2011. RCGP Conference May 2011

Pain and problem drug use

Practice Protocol. Buprenorphine Guidance Protocol

MEDICAID DRUG SPENDING ON ANTI- ADDICTION MEDICATION AND OPIOID ADDICTION REFRESHER

5317 Cherry Lawn Rd, Huntington, WV Phone: (304) Fax: (304) Welcome

Addictions Services Northumberland Patient Information Leaflet

Various therapies are used in the

Opportunities to Test Effective Opiate Treatments

Best Practices in Opioid Dependence Treatment

Methadone treatment Information for service users Page

Dependence and Addiction. Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania

Prescribers required to check PDMP before first prescription for Controled Substances for new patient.

Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District

Dr. Bayla Schecter, Addictions Specialist Helen Brown, RN Intake Nurse Louise Hill, MSW Addiction Outpatient Treatment (Quadra Clinic) Coordinator

Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT

EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II

CRITERIA FOR DIAGNOSIS AND MANAGEMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN ADULTS

Title: The Certified Medication Assisted Treatment Advocate (CMA) Training Course

ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15

SPECIFICATION FOR THE LOCAL COMMISSIONED SERVICE FOR THE MANAGEMENT ALCOHOL MISUSE

KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE

In 2010, approximately 8 million Americans 18 years and older were dependent on alcohol.

SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK

How To Treat An Addict

Jennifer Sharpe Potter, PhD, MPH Associate Professor Division of Alcohol and Drug Addiction Department of Psychiatry

Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain

Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence

Getting the best result from Opioid medicine. in the management of chronic pain

The Truth About Suboxone Russell Ferstandig, M.D. Diplomate American Board of Addition Medicine 2014, Russell Ferstandig, M.D., All Rights Reserved

Aproved by order No 702 as of by the Ministry of Health Care

Transcription:

A Nurse Practitioner led opiate substitution prescribing clinic The X First Forty Fifty Four Stephen Ling Nurse Practitioner Drug and Alcohol, Hunter New England Local Health District Conjoint Teacher, University of Newcastle, Faculty of Health, School of Nursing and Midwifery

A Nurse Led Opiate Treatment Clinic Endorsed as a Nurse Practitioner June 2004 Completion of the Opiate Treatment Accreditation Course 2009 5 authorities to prescribe opiate substitution treatment prior to the commencement of the clinic An area of need identified by the Drug and Alcohol Clinical Services management Negotiation between services

Commenced September 2011 Predominantly Justice Health patients Also other patients moved to the clinic 1 x 4 hour session/week 1 hour consultation new patients 30 minute follow up appointments 30 minute follow up appointments for other prescribers patients

1 Registered Nurse to case manage Staff Specialist availability and team case review meetings

Opiate Substitution Treatment NSW/Aus The Commonwealth Government Department of Health and Ageing: supplies methadone and buprenorphine (free of charge) pays for services by doctors (Medicare) approves formulation and registration of products Therapeutic Goods Administration, also responsible for recall of faulty products national policies and guidelines on the use of methadone and buprenorphine national policies and guidelines on training tracks use of narcotics.

The NSW State Government The Poisons and Therapeutic Goods Act 1966 (NSW) and Regulations (2002) provide for: the authorisation of medical practitioners and nurse practitioners as prescribers of opioid treatments the review, amendment, and cancellation of medical practitioners or nurse practitioners authorities to prescribe

procedures to allow drug dependent patients access to treatment licensing of private clinics investigation of complaints regarding prescribing and the professional behaviour of prescribers regulation of labelling, packing, storage, prescription and supply of products record-keeping on the use of drugs of addiction.

Initial Interview I am a Nurse Practitioner not a Doctor Substance use history Including current treatment Health history and examination Including Hepatitis C, mental health, allergies, other medications, and examination of injection sites, signs of intoxication/withdrawal (NO EXAMINATION TABLE) Social situation and supports Authority to prescribe Development of a treatment plan and prescription Oh, and you need a GP and tell them of your treatment!

Results September 2011 June 2013 Mixed retrospective prospective audit 54 patients to date 5 signed prior to commencement of the clinic 49 since commencing the clinic

Gender of patients 13 male female 41

Reason for treatment opiate dependent and 35 30 25 20 15 10 5 0 Justice health Justice health + pregnant chronic pain other

Other Conditions Perforated duodenal ulcer and NSAID S+codeine Gastric ulcers and NSAID S+codeine Mitral valve replacement and over the counter analgesics Infective endocarditis Acute pain x 4 Critically low albumin Septic knee Self harm Needle tip as a foreign body Transfer from satellite clinic

Treatment type 45 40 35 30 25 20 15 10 5 0 42 8 4 Methadone Suboxone Subutex

35 30 25 Origin and treatment type 20 15 10 Buprenorphine Methadone 5 0 Justice health Justice health + pregnant chronic pain other

What has happened to the patients? 25 22 20 15 10 5 0 Still prescribing 4 transferred to another prescriber at clinic 5 transferred to a satellite clinic 6 external prescriber 3 request to cease 7 return to JH 6 fail to attend 1 Involuntary reduction

42 Methadone 35-200mg 12 Buprenorphine 1.6-32mg

Other Events 3 patients converted from methadone to Suboxone 1 patient reduced to cessation (opioid bowel syndrome) 1 patient ceased to attend before completing reduction 1 transferred to another prescriber at the clinic 1 patient converted from Subutex to methadone 1 patient converted from Suboxone to methadone

The sky hasn t fallen One patient has died had ceased treatment 1 adverse drug event not critical

Request to Cease 1 patient couldn t afford treatment 1 patient didn t like the treatment 1 patient on medical grounds

Patients Who Jumped 1 patient failed to attend for change in dosing point 1 patient? found a prescriber of opioid analgesics 1 patient? to escape Community Services 1 patient never really engaged and acutely suicidal 1 described amphetamines as drug of choice anyway 1 patient? due to serving out parole period

Lessons learnt Patients released from Justice Health Compliance Behaviour The hazards of over the counter analgesics Buprenorphine and persistent pain Defining stability Opiate dependence treatment and benzodiazepines Attendance at Friday clinics? Signing scripts for the invisible patient

Questions and issues Why are there more patients on methadone? Why have people stopped treatment or changed prescriber? Am I doing something wrong? Has there been value in having a Nurse Practitioner led clinic? Do we need more drug and alcohol Nurse Practitioners?

References NSW Health. (2006). Opioid Treatment Program: Clinical Guidelines for methadone and buprenorphine treatment http://www0.health.nsw.gov.au/policies/gl/200 6/pdf/GL2006_019.pdf

Thanks to the staff of Newcastle Pharmacotherapy Service and the John Hunter Hospital

stephen.ling@hnehealth.nsw.gov.au THANK YOU